Literature DB >> 9862720

Intrinsic defects in macrophage IL-12 production associated with immune dysfunction in the MRL/++ and New Zealand Black/White F1 lupus-prone mice and the Leishmania major-susceptible BALB/c strain.

D G Alleva1, S B Kaser, D I Beller.   

Abstract

We have demonstrated that macrophages (Mphi) from young, prediseased, lupus-prone MRL/++ and New Zealand Black/White F1 mice display defective production of TNF-alpha, IL-1, and IL-6, but normal production of IL-10. In an attempt to determine the potential functional implications of this phenotype for autoimmunity, we demonstrate here that endotoxin-activated Mphi from these lupus-prone mice showed dramatically reduced expression of IL-12, a cytokine essential for Th1 responses that may be defective during lupus. IL-12 production was also reduced by Mphi from the control BALB/c strain, compatible with the concept that a genetically programmed deficit in IL-12 levels may underlie the IL-4-dominated BALB/c response to infection by the parasite Leishmania major. Although both IL-12 and TNF-alpha expression defects by Mphi from lupus-prone strains are expressed rapidly after activation, treatment with each cytokine demonstrated that only TNF-alpha contributes to the subsequent dysregulation of Mphi IL-1 and IL-6 expression in these strains, and that the reduced autocrine activity of defective IL-12 or TNF-alpha levels was not causal to each other. Although the intrinsic defect in IL-12 expression by lupus-prone and BALB/c Mphi may lead to defective Th1 responses, these Mphi responded to the Th1-derived cytokine, IFN-gamma, in a normal fashion suggesting a defective role in the induction, rather than the propagation, of Th1 responses in these mice. Our finding of a conserved intrinsic defect in IL-12 production by Mphi from the two principal mouse models of multigenic lupus provides insight into how excessive humoral responses may develop, and perhaps be prevented, in systemic autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9862720

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Tumour necrosis factor and other cytokines in murine lupus.

Authors:  A N Theofilopoulos; B R Lawson
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

2.  Innate immune responses in lupus-prone Palmerston North mice: differential responses to LPS and bacterial DNA/CpG oligonucleotides.

Authors:  Petar Lenert; Adam Goeken; Barry S Handwerger; Robert F Ashman
Journal:  J Clin Immunol       Date:  2003-05       Impact factor: 8.317

3.  Co-delivery of curcumin and doxorubicin in PEGylated liposomes favored the antineoplastic C26 murine colon carcinoma microenvironment.

Authors:  Alina Sesarman; Lucia Tefas; Bianca Sylvester; Emilia Licarete; Valentin Rauca; Lavinia Luput; Laura Patras; Sebastian Porav; Manuela Banciu; Alina Porfire
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

Review 4.  Ebola: translational science considerations.

Authors:  Francesco Chiappelli; Andre Bakhordarian; April D Thames; Angela M Du; Allison L Jan; Melissa Nahcivan; Mia T Nguyen; Nateli Sama; Ercolano Manfrini; Francesco Piva; Rafael Malagoli Rocha; Carl A Maida
Journal:  J Transl Med       Date:  2015-01-16       Impact factor: 5.531

5.  Effect of an exogenous trigger on the pathogenesis of lupus in (NZB x NZW)F1 mice.

Authors:  Hideo Yoshida; Minoru Satoh; Krista M Behney; Chee-Gun Lee; Hanno B Richards; Victoria M Shaheen; Jun-Qi Yang; Ram R Singh; Westley H Reeves
Journal:  Arthritis Rheum       Date:  2002-08

6.  NKG2D-RAE-1 receptor-ligand variation does not account for the NK cell defect in nonobese diabetic mice.

Authors:  Lisa M Maier; Sarah K Howlett; Kara M Rainbow; Jan Clark; Joanna M M Howson; John A Todd; Linda S Wicker
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

7.  Cytokine-induced monocyte characteristics in SLE.

Authors:  Zhe Zhang; Kelly Maurer; Juan C Perin; Li Song; Kathleen E Sullivan
Journal:  J Biomed Biotechnol       Date:  2010-06-24

8.  A small peptide (CEL-1000) derived from the beta-chain of the human major histocompatibility complex class II molecule induces complete protection against malaria in an antigen-independent manner.

Authors:  Yupin Charoenvit; Gary T Brice; David Bacon; Victoria Majam; Jackie Williams; Esteban Abot; Harini Ganeshan; Martha Sedegah; Denise L Doolan; Daniel J Carucci; Daniel H Zimmerman
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

9.  Type I Interferon-Activated STAT4 Regulation of Follicular Helper T Cell-Dependent Cytokine and Immunoglobulin Production in Lupus.

Authors:  Xuemei Dong; Olivia Q Antao; Wenzhi Song; Gina M Sanchez; Krzysztof Zembrzuski; Fotios Koumpouras; Alexander Lemenze; Joe Craft; Jason S Weinstein
Journal:  Arthritis Rheumatol       Date:  2021-01-29       Impact factor: 10.995

10.  Immune dysregulation as a cause of autoinflammation in fragile X premutation carriers: link between FMRI CGG repeat number and decreased cytokine responses.

Authors:  Milo Careaga; Destanie Rose; Flora Tassone; Robert F Berman; Randi Hagerman; Paul Ashwood
Journal:  PLoS One       Date:  2014-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.